Investments
8Portfolio Exits
3About Salt Lake Life Science Angels
Salt Lake Life Science Angels (SLLSA) is a not-for-profit corporation organized to facilitate investment in seed-stage healthcare and life science companies in Utah and the Mountain West. SLLSA is made up of approximately twenty accredited executives, entrepreneurs, scientists, and clinicians seeking investment opportunities in early-stage companies. SLLSA strives to be a benefit to both its angel investor members and to the communityï¾'s start-up companies.
Salt Lake Life Science Angels Headquarter Location
Salt Lake City, Utah,
United States
Latest Salt Lake Life Science Angels News
Apr 26, 2012
Tweet Salt Lake City-based Wasatch Microfluidics , a developer of protein analysis equipment for the drug discovery and research market, has raised $470,000 in a funding round from an angel group, part of a targeted $1M funding for the company. According to the Pasadena Angels, a Southern California angel investment group, it invested in Wasatch Microfluidics to help the firm combine its patented protein printing technology with an SPR biosensor, as well as help its platform technology move closer to a multiple product line. Wasatch Microfluidics is headed by Josh Eckman, and also has previously scored funding from the Salt Lake Life Science Angels and Utah Angels. The firm's technology is based on research developed at the University of Utah Research Foundation. More information »
Salt Lake Life Science Angels Investments
8 Investments
Salt Lake Life Science Angels has made 8 investments. Their latest investment was in iVeena Delivery Systems as part of their Series A on May 5, 2015.
Salt Lake Life Science Angels Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
5/1/2015 | Series A | iVeena Delivery Systems | $1.3M | Yes | 2 | |
7/1/2014 | Series C | |||||
12/31/2013 | Angel | |||||
4/15/2011 | Angel | |||||
1/20/2010 | Angel |
Date | 5/1/2015 | 7/1/2014 | 12/31/2013 | 4/15/2011 | 1/20/2010 |
---|---|---|---|---|---|
Round | Series A | Series C | Angel | Angel | Angel |
Company | iVeena Delivery Systems | ||||
Amount | $1.3M | ||||
New? | Yes | ||||
Co-Investors | |||||
Sources | 2 |
Salt Lake Life Science Angels Portfolio Exits
3 Portfolio Exits
Salt Lake Life Science Angels has 3 portfolio exits. Their latest portfolio exit was Tute Genomics on October 12, 2016.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
10/12/2016 | Acquired | 4 | |||
Date | 10/12/2016 | ||
---|---|---|---|
Exit | Acquired | ||
Companies | |||
Valuation | |||
Acquirer | |||
Sources | 4 |
Salt Lake Life Science Angels Team
1 Team Member
Salt Lake Life Science Angels has 1 team member, including current Managing Director, Andrew Laver.
Name | Work History | Title | Status |
---|---|---|---|
Andrew Laver | Managing Director | Current |
Name | Andrew Laver |
---|---|
Work History | |
Title | Managing Director |
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.